venBio Partners’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-596,483
| Closed | -$20.3M | – | 8 |
|
|
2022
Q3 | $20.3M | Sell |
596,483
-1,575,181
| -73% | -$53.6M | 4.7% | 5 |
|
|
2022
Q2 | $20.5M | Hold |
2,171,664
| – | – | 5.84% | 7 |
|
|
2022
Q1 | $30.8M | Hold |
2,171,664
| – | – | 6.83% | 6 |
|
|
2021
Q4 | $45.9M | Sell |
2,171,664
-29,114
| -1% | -$616K | 8.28% | 4 |
|
|
2021
Q3 | $49.2M | Hold |
2,200,778
| – | – | 4.9% | 3 |
|
|
2021
Q2 | $54.6M | Sell |
2,200,778
-243,533
| -10% | -$6.04M | 6.44% | 3 |
|
|
2021
Q1 | $70.9M | Hold |
2,444,311
| – | – | 6.74% | 3 |
|
|
2020
Q4 | $63.1M | Hold |
2,444,311
| – | – | 5.57% | 3 |
|
|
2020
Q3 | $75.3M | Sell |
2,444,311
-705,708
| -22% | -$21.7M | 11.44% | 3 |
|
|
2020
Q2 | $78.5M | Hold |
3,150,019
| – | – | 65.27% | 1 |
|
|
2020
Q1 | $66.8M | Sell |
3,150,019
-790,524
| -20% | -$16.8M | 56.91% | 1 |
|
|
2019
Q4 | $87.5M | Sell |
3,940,543
-14,315
| -0.4% | -$318K | 37.5% | 1 |
|
|
2019
Q3 | $90M | Hold |
3,954,858
| – | – | 42.68% | 1 |
|
|
2019
Q2 | $75.7M | Buy |
+3,954,858
| New | +$75.7M | 33.61% | 1 |
|